A phase II study of continuous infusion 5‐fluorouracil in advanced hormone refractory prostate cancer: An Illinois cancer center study

Jacob Lokich; Timothy M. Kuzel; Martin S. Tallman

doi:10.1002/1097-0142(19940301)73:5<1536::AID-CNCR2820730538>3.0.CO;2-1

A phase II study of continuous infusion 5‐fluorouracil in advanced hormone refractory prostate cancer: An Illinois cancer center study

Jacob Lokich^*, Timothy M. Kuzel, Martin S. Tallman

^*Corresponding author for this work

Dermatology

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	1536-1537
Number of pages	2
Journal	cancer
Volume	73
Issue number	5
DOIs	https://doi.org/10.1002/1097-0142(19940301)73:5<1536::AID-CNCR2820730538>3.0.CO;2-1
State	Published - Mar 1 1994

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/1097-0142(19940301)73:5<1536::AID-CNCR2820730538>3.0.CO;2-1

Cite this

@article{1f1ea69c06684db6a97a36b56eb683fe,

title = "A phase II study of continuous infusion 5‐fluorouracil in advanced hormone refractory prostate cancer: An Illinois cancer center study",

author = "Jacob Lokich and Kuzel, {Timothy M.} and Tallman, {Martin S.}",

year = "1994",

month = mar,

day = "1",

doi = "10.1002/1097-0142(19940301)73:5<1536::AID-CNCR2820730538>3.0.CO;2-1",

language = "English (US)",

volume = "73",

pages = "1536--1537",

journal = "cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "5",

}

TY - JOUR

T1 - A phase II study of continuous infusion 5‐fluorouracil in advanced hormone refractory prostate cancer

T2 - An Illinois cancer center study

AU - Lokich, Jacob

AU - Kuzel, Timothy M.

AU - Tallman, Martin S.

PY - 1994/3/1

Y1 - 1994/3/1

UR - http://www.scopus.com/inward/record.url?scp=0028256384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028256384&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19940301)73:5<1536::AID-CNCR2820730538>3.0.CO;2-1

DO - 10.1002/1097-0142(19940301)73:5<1536::AID-CNCR2820730538>3.0.CO;2-1

M3 - Letter

C2 - 8111726

AN - SCOPUS:0028256384

SN - 0008-543X

VL - 73

SP - 1536

EP - 1537

JO - cancer

JF - cancer

IS - 5

ER -

A phase II study of continuous infusion 5‐fluorouracil in advanced hormone refractory prostate cancer: An Illinois cancer center study

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this